Cargando…
A convenient diagnostic tool for discriminating adult-onset glutamic acid decarboxylase antibody-positive autoimmune diabetes from type 2 diabetes: a retrospective study
BACKGROUND: The glutamic acid decarboxylase antibody (GADA) test, commonly used to diagnose autoimmune diabetes, is not cost-effective in areas of low prevalence. The aim of this study was to develop a convenient tool to discriminate adult-onset GADA-positive autoimmune diabetes from type 2 diabetes...
Autores principales: | Sia, Hon-Ke, Tu, Shih-Te, Liao, Pei-Yung, Lin, Kuan-Han, Kor, Chew-Teng, Yeh, Ling-Ling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7025710/ https://www.ncbi.nlm.nih.gov/pubmed/32095379 http://dx.doi.org/10.7717/peerj.8610 |
Ejemplares similares
-
Predictors of treatment failure during the first year in newly diagnosed type 2 diabetes patients: a retrospective, observational study
por: Sia, Hon-Ke, et al.
Publicado: (2021) -
Association between smoking and glycemic control in men with newly diagnosed type 2 diabetes: a retrospective matched cohort study
por: Sia, Hon-Ke, et al.
Publicado: (2022) -
Self-monitoring of blood glucose in association with glycemic control in newly diagnosed non-insulin-treated diabetes patients: a retrospective cohort study
por: Sia, Hon-Ke, et al.
Publicado: (2021) -
Cytotoxic T cells specific for glutamic acid decarboxylase in autoimmune diabetes
Publicado: (1995) -
Neurological Manifestations of Glutamic Acid Decarboxylase Autoimmunity in Indian Patients
por: Thevarkalam, Meena, et al.
Publicado: (2023)